Gilead has blamed the low rate of respiratory syncytial virus infections last season for ending two midstage trials of obeldesivir.

Gilead Sciences (NasdaqGS:GILD) recently entered an exclusive agreement with Kymera Therapeutics to advance a molecular glue degrader program targeting CDK2, enhancing its oncology pipeline ...

Kymera signs $750 million CDK2 drug deal with Gilead and earns $20 million from Sanofi as KT-485 advances toward clinical trials in inflammatory diseases.

If you haven’t heard of The Handmaid’s Tale by now, you’ve probably been living under a rock or maybe in your own personal Gilead.

Gilead Sciences has joined the list of pharma groups hiking their capital investment plans in the US, adding $11 billion in new spending as the industry prepares for potential sector-specific tariffs.

AIDS Healthcare Foundation (AHF) denounces Gilead Sciences for once again excluding Latin America and the Caribbean (LAC) from affordable access to a groundb ...

(RTTNews) - Gilead Sciences, Inc. (GILD) and Kymera Therapeutics, Inc. (KYMR) announced Wednesday that they have entered into an exclusive option and license agreement to accelerate the ...

Mount Gilead earned a boys track and field district championship on May 24, running its streak to four in a row. This is how MG pulled it off.

Gilead faces lawsuit over HIV drug pricing Gilead and other pharma companies stand accused of engaging in a scheme to block cheaper competitors to life-saving HIV drugs from entering the market.

The Investment Committee give you their top stocks to watch for the second half.

View the latest weather forecasts, maps, news and alerts on Yahoo Weather. Find local weather forecasts for Mount Gilead, United States throughout the world ...

Review quarterly and annual revenue, net income, and cash flow for Gilead Sciences Inc (GILD:XNAS) stock through the last fiscal year.